Publishing Model: Open Access Deadline: Oct 31, 2026 Incretin-Based Therapies in Type 2 Diabetes and Obesity: Current Evidence and the Evolving Cardiometabolic Landscape Cardiovascular Diabetology features a Collection on "Incretin-Based Therapies in Type 2 Diabetes and Obesity: Current Evidence and the Evolving Cardiometabolic Landscape"
Insulin, sulfonylureas, narrow-therapeutic-window medications, and any drug where absorption timing matters are all worth flagging
Conversely, cytotoxic effects were observed with a DHA dose greater than 5 mM
NAION causes sudden, painless vision loss in one eye
Researchers and scientists are continuously seeking synergistic approaches to complex biological systems
It stimulates an increased rate of testosterone in the human body, allowing for more growth in muscle